HIF Inhibition and Emerging Therapeutic Targets in Clear Cell Renal Cell Carcinoma. Canadian Oncology Today, [S. l.], v. 3, n. 1, p. 34–39, 2026. DOI: 10.58931/cot.2026.3148. Disponível em: https://canadianoncologytoday.com/article/view/3-1-Gangadharaiah_et_al. Acesso em: 14 apr. 2026.